Joseph J Wolk sold $2.0M of Johnson & Johnson (JNJ)

Executed Feb 7 2025, disclosed Feb 11 2025, 4 days later.

Value, as filed

$2.0M

13,015 sh × $153.89

Executed

Feb 7 2025

the trade date, as filed

Disclosed

Feb 11 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JW Joseph J Wolk Exec VP, CFO profile →

Joseph J Wolk (Exec VP, CFO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Johnson & Johnson (JNJ). The largest single filing was $21.8M of JNJ (89,654 sh across 4 lots, as filed), executed Feb 17.

The name

JNJ Johnson & Johnson JNJ · Healthcare · 87 filings in 24 months ticker →

Healthcare · Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Joseph J Wolk in JNJ

JNJSALE Johnson & Johnson $21.8M
89,654 sh across 4 lots
Exec Feb 17
Filed Feb 18 · 5:30 PM ET JNJSALE Johnson & Johnson $3.0M
16,820 sh × $176.91
Exec Aug 15 2025
Filed Aug 18 2025 · 5:30 PM ET